(IHF) iShares U.S. Healthcare - Ratings and Ratios
Healthcare, Providers, Stocks, U.S., Sector
Description: IHF iShares U.S. Healthcare
The iShares U.S. Healthcare Providers ETF (IHF) is designed to track the performance of the healthcare providers sector in the U.S. equity market, as defined by S&P Dow Jones Indices. By investing at least 80% of its assets in the component securities of its index, the fund provides exposure to a specific segment of the healthcare industry. The remaining 20% can be invested in derivatives such as futures, options, and swap contracts, as well as cash and cash equivalents, allowing for flexibility in managing the portfolio.
The healthcare providers sector includes companies involved in delivering healthcare services, such as hospitals, nursing homes, and healthcare facilities. The funds focus on this specific area allows investors to tap into the growth potential of the healthcare industry, driven by factors such as an aging population and increasing demand for healthcare services. As a non-diversified fund, IHF is more concentrated in its holdings, which can result in higher volatility.
Analyzing the
Forecasting the future performance of IHF, we can expect the fund to be influenced by the overall trend in the healthcare providers sector. If the sector continues to grow, driven by demographic changes and healthcare reform, IHF is likely to benefit. However, the current technical indicators suggest a short-term bullish trend, while the longer-term trend remains bearish. Therefore, a potential trading strategy could involve monitoring the funds price action around its SMAs and adjusting positions accordingly. A break above the 50-day SMA could signal a buying opportunity, while a drop below the 20-day SMA might indicate a sell signal.
Additional Sources for IHF ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
IHF ETF Overview
Market Cap in USD | 632m |
Category | Health |
TER | 0.40% |
IPO / Inception | 2006-05-01 |
IHF ETF Ratings
Growth Rating | 3.30 |
Fundamental | - |
Dividend Rating | 40.6 |
Rel. Strength | -23.1 |
Analysts | - |
Fair Price Momentum | 39.34 USD |
Fair Price DCF | - |
IHF Dividends
Dividend Yield 12m | 0.91% |
Yield on Cost 5y | 1.18% |
Annual Growth 5y | 10.45% |
Payout Consistency | 61.2% |
Payout Ratio | % |
IHF Growth Ratios
Growth Correlation 3m | -72.1% |
Growth Correlation 12m | -80.6% |
Growth Correlation 5y | 33.4% |
CAGR 5y | 4.14% |
CAGR/Max DD 5y | 0.19 |
Sharpe Ratio 12m | 0.11 |
Alpha | -21.37 |
Beta | 0.442 |
Volatility | 27.54% |
Current Volume | 203.5k |
Average Volume 20d | 154.9k |
Stop Loss | 43.6 (-3.6%) |
As of July 14, 2025, the stock is trading at USD 45.22 with a total of 203,507 shares traded.
Over the past week, the price has changed by -1.61%, over one month by -5.50%, over three months by -17.00% and over the past year by -13.57%.
Neither. Based on ValueRay´s Analyses, iShares U.S. Healthcare is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 3.30 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IHF is around 39.34 USD . This means that IHF is currently overvalued and has a potential downside of -13%.
iShares U.S. Healthcare has no consensus analysts rating.
According to our own proprietary Forecast Model, IHF iShares U.S. Healthcare will be worth about 43.9 in July 2026. The stock is currently trading at 45.22. This means that the stock has a potential downside of -2.83%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 43.9 | -2.8% |